Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-1560
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease ; day:13 ; month:5 ; year:2016 ; pages:1-12
Clinical autonomic research ; (13.5.2016), 1-12
- Creator
-
Arnhold, Mike
- Contributor
-
Dening, Yanina
Chopin, Michaël
Arévalo, Esteban
Schwarz, Mathias
Reichmann, Heinz
Gille, Gabriele
Funk, Richard H. W.
Pan-Montojo, Francisco
SpringerLink (Online service)
- DOI
-
10.1007/s10286-016-0358-6
- URN
-
urn:nbn:de:1111-2016051820408
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arnhold, Mike
- Dening, Yanina
- Chopin, Michaël
- Arévalo, Esteban
- Schwarz, Mathias
- Reichmann, Heinz
- Gille, Gabriele
- Funk, Richard H. W.
- Pan-Montojo, Francisco
- SpringerLink (Online service)
Other Objects (12)
Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
Innervation von Schweißdrüsen bei Patienten mit Morbus Parkinson
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Remodelling sympathetic innervation in rat pancreatic islets ontogeny
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
Innervation von Schweißdrüsen bei Patienten mit Morbus Parkinson
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Remodelling sympathetic innervation in rat pancreatic islets ontogeny
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Microbial biomarker discovery in Parkinson’s disease through a network-based approach
Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
Innervation von Schweißdrüsen bei Patienten mit Morbus Parkinson
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Ecto-GPR37: a potential biomarker for Parkinson’s disease
Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson’s disease
Fatigue in fluctuating Parkinson’s disease patients: possible impact of safinamide
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Remodelling sympathetic innervation in rat pancreatic islets ontogeny
Mitochondrial DNA in Extracellular Vesicles : A Diagnostic Biomarker for Parkinson’s Disease?
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease